Wesbanco Bank Inc. Acquires 289 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Wesbanco Bank Inc. grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.8% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,505 shares of the medical equipment provider’s stock after buying an additional 289 shares during the quarter. Wesbanco Bank Inc.’s holdings in Intuitive Surgical were worth $745,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. Brighton Jones LLC raised its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock worth $1,916,000 after acquiring an additional 731 shares in the last quarter. Union Bancaire Privee UBP SA bought a new position in Intuitive Surgical during the 4th quarter valued at about $6,509,000. Kingsview Wealth Management LLC boosted its position in Intuitive Surgical by 2.2% in the fourth quarter. Kingsview Wealth Management LLC now owns 4,354 shares of the medical equipment provider’s stock valued at $2,273,000 after buying an additional 94 shares in the last quarter. Stephens Inc. AR grew its stake in Intuitive Surgical by 8.9% during the fourth quarter. Stephens Inc. AR now owns 8,943 shares of the medical equipment provider’s stock worth $4,668,000 after buying an additional 732 shares during the last quarter. Finally, Bank of Stockton increased its holdings in shares of Intuitive Surgical by 13.5% during the fourth quarter. Bank of Stockton now owns 1,161 shares of the medical equipment provider’s stock worth $606,000 after buying an additional 138 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the business’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 216 shares of the business’s stock in a transaction dated Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares of the company’s stock, valued at approximately $510,740.77. The trade was a 19.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 16,543 shares of company stock worth $8,375,072. 0.70% of the stock is owned by insiders.

Intuitive Surgical Trading Down 5.6%

NASDAQ ISRG opened at $526.15 on Tuesday. The stock has a 50-day simple moving average of $522.38 and a 200 day simple moving average of $539.01. The company has a market capitalization of $188.58 billion, a PE ratio of 82.08, a P/E/G ratio of 5.85 and a beta of 1.67. Intuitive Surgical, Inc. has a 12 month low of $413.52 and a 12 month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. During the same quarter in the prior year, the company posted $1.50 earnings per share. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on ISRG shares. Citigroup reissued a “buy” rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Barclays cut their price objective on Intuitive Surgical from $684.00 to $635.00 and set an “overweight” rating for the company in a research report on Thursday, April 24th. Truist Financial cut their price objective on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating for the company in a research report on Wednesday, April 23rd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the company a “buy” rating in a research report on Monday, April 14th. Finally, Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Thursday, June 5th. One analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $588.95.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.